Shohboz Muxtorov , Shirin Ochilova , Dilshod Saydullayev
According to the International Diabetes Federation (IDF), in 2019, the number of people with diabetes mellitus (DM) exceeded 463 million people [1]. In Russia, according to the State Register of Patients with Diabetes mellitus for 2018, their number was 4.58 million, which is 3.1% of the country's population. These data show only the number of patients registered in the dispensary, but according to the All-Russian Epidemiological Study on Type 2 Diabetes NATION, there is a significantly larger group of people who are unaware of their disease [2]. The number of undiagnosed cases reaches about 46%, which increases the total number of patients with diabetes in Russia to 8.5-9 million people, which is already about 6% of the population [3]. Patients in this category do not receive the necessary therapy and are not warned about the complications that diabetes can cause. These include patients with ocular pathology in the anterior segment of the eye - secondary neovascular glaucoma (NG) complicated by cataracts, corneal ulcers, etc., and in the posterior segment - hemophthalmos and retinal detachment caused by the unfavorable development of diabetic retinopathy (DR) [4].
